WhatsApp
backNews Article

Gland Pharma Grants 85,317 Employee Stock Options to Two Employees Under ESOP 2025

Options vest in three installments starting November 16, 2027, with exercise prices ranging from INR 1 to INR 1,692.95

Gland Pharma Limited approved the grant of 85,317 employee stock options to 2 employees under its Employee Stock Option Scheme 2025, with a vesting schedule over three years and exercise price based partly on market price and partly on face value. The options vest starting November 16, 2027, and can be exercised within two years of vesting.

1 day ago|GLAND-0.55%
Gland Pharma Limited543245GLANDCorporate Action

Gland Pharma Limited

Corporate Action

Gland Pharma Limited's ESOP Compensation Committee approved granting 85,317 employee stock options to two employees under the ESOP 2025 scheme, with a detailed vesting schedule and pricing formula.

The stock options are granted under SEBI regulations governing share-based employee benefits and sweat equity, aligning with compliance requirements.

Out of the total options, 56,309 options are priced at INR 1,692.95 each, which is 50% of the equity share closing price on the National Stock Exchange as of the grant date, November 16, 2026.

The remaining 29,008 options are priced at the face value of INR 1 each.

The vesting schedule begins one year after the grant date, with 34% vesting on November 16, 2027, followed by 33% vesting each on November 16, 2028 and November 16, 2029, respectively.

Employees have up to two years from each vesting date to exercise their options under the scheme administered by the ESOP Compensation Committee.

Highlights

  • Total of 85,317 stock options granted to 2 employees under ESOP 2025.
  • 56,309 options priced at INR 1,692.95; 29,008 options priced at INR 1 (face value).
  • Vesting occurs in three tranches over three years starting November 16, 2027.
  • Options must be exercised within two years of respective vesting date.
  • Grant complies with SEBI (Share Based Employee Benefits & Sweat Equity) Regulations, 2021.

Key Data Snapshot

Total stock options granted85,317 options
Number of employees granted options2 employees
Pricing for 56,309 optionsINR 1,692.95 per option
Pricing for 29,008 optionsINR 1 per option (face value)
Vesting schedule34% on 16-Nov-2027; 33% on 16-Nov-2028; 33% on 16-Nov-2029
Exercise periodWithin 2 years from the date of vesting

What happened

  • Gland Pharma's ESOP Compensation Committee approved the grant of 85,317 employee stock options to 2 employees.
  • This grant was approved at a meeting held on November 16, 2026.
  • The options are granted under the Employee Stock Option Scheme (ESOP) 2025 of Gland Pharma.
  • The grant is in accordance with SEBI regulations on share-based employee benefits and sweat equity.

Key details

  • 56,309 options are priced at INR 1,692.95, which is 50% of the equity share closing price on NSE on grant date.
  • 29,008 options are priced at INR 1, equal to face value of the equity share.
  • Vesting occurs in three phases: 34% after 1 year, 33% after 2 years, and 33% after 3 years from the grant date.
  • Employees have up to two years post vesting to exercise the options.
  • The scheme is managed by the ESOP Compensation Committee of the Board.

Regulatory and governance context

  • The grant complies with the SEBI (Share Based Employee Benefits & Sweat Equity) Regulations, 2021 as amended.
  • Required disclosures are made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

More News on Corporate Action

View all

Latest corporate announcements and market updates in Corporate Action.

View all news
Gland Pharma Grants 85,317 Employee Stock Options to Two | Stockk News